Dr. Verneris is a pediatric hematologist and oncologist at the CU School of Medicine and director of Bone Marrow Transplantation and Cellular Therapy at Children’s Hospital Colorado, where he holds the Barton Family Endowed Chair of Bone Marrow Transplant. Dr. Verneris specializes in pediatric leukemia, and his clinical research focuses on using the immune system to treat refractory cancer, whether through bone marrow transplantation or cellular therapy. His pioneering research has progressed the field of cellular therapy to greater heights, while advancing new cures and therapies that are saving lives.

Dr. Keating is an associate professor of pediatrics at the CU School of Medicine and medical director of the Blood Marrow Transplant and Cellular Therapeutics clinical program at Children’s Hospital Colorado. Dr. Keating specializes in pediatric blood and marrow transplants, and her discoveries are helping to drive the next generation of trailblazing new cancer cures. Her research focuses primarily on the development of clinical trials for pediatric leukemia patients, with a particular interest in cellular therapeutics to improve outcomes and reduce side effects for children with relapsed cancer.

Dr. Kamdar is an associate professor and the clinical director of the lymphoma program in the Division of Hematology at the CU School of Medicine. Her clinical research focuses primarily on chemotherapy-free cellular therapy, and her work is helping to advance more effective, less toxic treatments for the hardest-to-treat cancers. One of her recent studies showed tremendous promise in utilizing CAR T-cell therapies to improve survival rates for patients with relapsed large B-cell lymphoma, resulting in the first new treatment for the disease in 20+ years.